In prostate cancer cells, the reduced expression of ABCA1 with promoter hypermethylation maintains elevated intracellular cholesterol levels, contributing to aggressive prostate cancer progression (Lee et al. 2013). This evidence concerns the gene ABCA1 and prostate carcinoma.